Assessment of futility in clinical trials
- 5 May 2006
- journal article
- research article
- Published by Wiley in Pharmaceutical Statistics
- Vol. 5 (4), 273-281
- https://doi.org/10.1002/pst.216
Abstract
The term ‘futility’ is used to refer to the inability of a clinical trial to achieve its objectives. In particular, stopping a clinical trial when the interim results suggest that it is unlikely to achieve statistical significance can save resources that could be used on more promising research. There are various approaches that have been proposed to assess futility, including stochastic curtailment, predictive power, predictive probability, and group sequential methods. In this paper, we describe and contrast these approaches, and discuss several issues associated with futility analyses, such as ethical considerations, whether or not type I error can or should be reclaimed, one-sided vs two-sided futility rules, and the impact of futility analyses on power. Copyright © 2006 John Wiley & Sons, Ltd.Keywords
This publication has 23 references indexed in Scilit:
- A review of methods for futility stopping based on conditional powerStatistics in Medicine, 2005
- Bayesian predictive approach to interim monitoring in clinical trialsStatistics in Medicine, 2005
- Type I error and power in trials with one interim futility analysisPharmaceutical Statistics, 2004
- Over‐ruling a group sequential boundary—a stopping rule versus a guidelineStatistics in Medicine, 2003
- Stopping clinical trials because of treatment ineffectiveness: a comparison of a futility design with a method of stochastic curtailmentStatistics in Medicine, 2003
- Group sequential designs using both type I and type II error probability spending functionsCommunications in Statistics - Theory and Methods, 1998
- On the curtailment of samplingThe Canadian Journal of Statistics / La Revue Canadienne de Statistique, 1992
- [Investigating Therapies of Potentially Great Benefit: ECMO]: Comment: A Bayesian PerspectiveStatistical Science, 1989
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987